Genetic Association of Phosphodiesterases With Human Cognitive Performance

by Mark E. Gurney
Published 2019-02-01

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.

by Mengshi Zhou, Rong Xu, David C Kaelber, Mark E Gurney
Published 2020-01-01

Therapeutic benefits of phosphodiesterase 4B inhibition after traumatic brain injury.

by Nicole M Wilson, Mark E Gurney, W Dalton Dietrich, Coleen M Atkins
Published 2017-01-01

Effects of chronic inhibition of phosphodiesterase-4D on behavior and regional rates of cerebral protein synthesis in a mouse model of fragile X syndrome

by Michael Rosenheck, Carrie Sheeler, Rachel Michelle Saré, Mark E. Gurney, Carolyn Beebe Smith
Published 2021-11-01

A Novel PDE4D Inhibitor BPN14770 Reverses Scopolamine-Induced Cognitive Deficits via cAMP/SIRT1/Akt/Bcl-2 Pathway

by Yulu Wang, Yulu Wang, Shichao Gao, Victor Zheng, Ling Chen, Ling Chen, Ling Chen, Min Ma, Shichen Shen, Jun Qu, Hanting Zhang, Hanting Zhang, Mark E. Gurney, James M. O’Donnell, Ying Xu
Published 2020-12-01